SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.07-3.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: B.D. who wrote (27154)1/4/1999 7:46:00 PM
From: Exacctnt  Read Replies (2) of 32384
 
B.D. <<What would be the benefit of exercising at this point, versus later when (hopefully) the warrants are worth double-digits?>>

It is interesting that according to the press release, Ligand received $12.5M in the exercise of 2.27 million shares. That provides an exercise price at approx. $5.51 per share. That compares to the warrants stated exercise price of $7.12. It appears that a deal was made to allow these "institutions" to exercise at a lower price, which in turn, provides funds to Ligand.

From the release, "Ligand has agreed to pay a cost of money incentive to the investors for the early exercise of these warrants." The cost of money incentive appears to be the difference between $7.12 and $5.51 or around $1.61 per share. Seems to me to be very generous deal for those institutions.

The question to be answered, is Ligand desperate for cash? Kind of hard to believe after the Elan deal.

Regards,
Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext